Company profile
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in
- CEO
- Mr. Erik C. Emerson
- Headquarters
- Rutherford, NJ, United States
- Employees
- 15
- IPO date
- Apr 25, 2013
- Sector
- Healthcare
- Industry
- Medical Devices